Producer
CycloLab Cyclodextrin Research & Development Laboratory
Hungarian specialty cyclodextrin producer and research company; founded 1989 by cyclodextrin pioneer Dr. Jozsef Szejtli. Produces pharmaceutical-grade HP-beta-CD, SBE-beta-CD, and other modified cyclodextrins for pharmaceutical clients globally. Small but technically specialized; key supplier to pharma companies needing custom cyclodextrin complexes for poorly soluble drugs. Collaborates with Budapest University of Technology.
1
Inputs supplied
0
Goods downstream
1
Facilities
0
Stories
What they make
1 input CycloLab Cyclodextrin Research & Development Laboratory supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Pharmaceutical-Grade Cyclodextrins
55%Research & Analytical Services
25%Food & Cosmetic Grade Cyclodextrins
12%Industrial Cyclodextrin Applications
8%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Origin2022
Cyclolab Ltd., founded in Budapest, Hungary, is a leading research and development organization for cyclodextrins — cyclic oligosaccharide molecules produced from corn starch through enzymatic conversion, whose interior cavity can form inclusion complexes with hydrophobic drug molecules to improve their water solubility. Cyclodextrins are a defining example of a pharmaceutical enabling technology that is almost entirely unknown outside the pharmaceutical chemistry community: they convert poorly water-soluble drugs (many of the most clinically important compounds are hydrophobic) into injectable or oral formulations. Sulfobutylether-beta-cyclodextrin (SBECD) is the excipient in Gilead Sciences' remdesivir (Veklury) IV formulation — the first antiviral approved by the FDA for COVID-19 treatment. Without SBECD, remdesivir cannot be dissolved for intravenous administration. When remdesivir demand surged globally in 2020, SBECD supply became a constraining factor for remdesivir production — and SBECD production depends on beta-cyclodextrin upstream and specialized sulfobutylether chemistry. Cyclolab, as one of the specialized cyclodextrin research and production entities in Europe, operates in the narrow industrial niche where corn starch processing intersects with pharmaceutical formulation chemistry to enable treatments for conditions ranging from antifungal infections (voriconazole uses SBECD) to COVID antivirals.
Cyclolab Ltd. ↗